Macrophage Activation Syndrome and COVID 19: Impact of MAPK Driven Immune-Epigenetic Programming by SARS-Cov-2
出版年份 2021 全文链接
标题
Macrophage Activation Syndrome and COVID 19: Impact of MAPK Driven Immune-Epigenetic Programming by SARS-Cov-2
作者
关键词
-
出版物
Frontiers in Immunology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-10-02
DOI
10.3389/fimmu.2021.763313
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV
- (2021) Nima Hemmat et al. ARCHIVES OF VIROLOGY
- In silico analyses on the comparative sensing of SARS‐CoV‐2 mRNA by the intracellular TLRs of humans
- (2021) Abhigyan Choudhury et al. JOURNAL OF MEDICAL VIROLOGY
- mRNA-lncRNA Co-Expression Network Analysis Reveals the Role of lncRNAs in Immune Dysfunction during Severe SARS-CoV-2 Infection
- (2021) Sumit Mukherjee et al. Viruses-Basel
- Risk stratification by long non‐coding RNAs profiling in COVID‐19 patients
- (2021) Jie Cheng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- SARS-CoV-2 Switches ‘on’ MAPK and NFκB Signaling via the Reduction of Nuclear DUSP1 and DUSP5 Expression
- (2021) Swati Goel et al. Frontiers in Pharmacology
- SARS-CoV-2 takes its Toll
- (2021) Alan Sariol et al. NATURE IMMUNOLOGY
- Implications of the second wave of COVID-19 in India
- (2021) Purva Asrani et al. Lancet Respiratory Medicine
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
- (2020) Evangelos J. Giamarellos-Bourboulis et al. Cell Host & Microbe
- Correction to: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
- (2020) Qiurong Ruan et al. INTENSIVE CARE MEDICINE
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Considerations for Statin Therapy in Patients with COVID‐19
- (2020) Simin Dashti‐Khavidaki et al. PHARMACOTHERAPY
- COVID-19, acute respiratory distress syndrome (ARDS), and hyperbaric oxygen therapy (HBOT): what is the link?
- (2020) Antonio De Maio et al. CELL STRESS & CHAPERONES
- Tocilizumab for treatment of mechanically ventilated patients with COVID-19
- (2020) Emily C Somers et al. CLINICAL INFECTIOUS DISEASES
- p38 MAPK inhibition: A promising therapeutic approach for COVID-19
- (2020) Joseph M. Grimes et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response
- (2020) Radhakrishnan Vishnubalaji et al. Genes
- Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach
- (2020) Ahmad Abu Turab Naqvi et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Efficacy of tocilizumab in COVID‐19: A systematic review and meta‐analysis
- (2020) Muhammad Aziz et al. JOURNAL OF MEDICAL VIROLOGY
- Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
- (2020) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
- (2020) Shruti Gupta et al. JAMA Internal Medicine
- Tempering Macrophage Plasticity for Controlling SARS-CoV-2 Infection for Managing COVID-19 Disease
- (2020) Devinder Toor et al. Frontiers in Pharmacology
- Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
- (2020) Carlos Salama et al. NEW ENGLAND JOURNAL OF MEDICINE
- The lncRNA Neat1 promotes activation of inflammasomes in macrophages
- (2019) Pengfei Zhang et al. Nature Communications
- Towards Better Drug Repositioning: Targeted Immunoinflammatory Therapy for Diabetic Nephropathy
- (2019) Qin zhang et al. CURRENT MEDICINAL CHEMISTRY
- lncRNA Malat1 modulates the maturation process, cytokine secretion and apoptosis in airway epithelial cell‑conditioned dendritic cells
- (2018) Zhoubin Li et al. Experimental and Therapeutic Medicine
- Angiotensin-converting enzyme 2-angiotensin (1-7)-Mas axis prevents pancreatic acinar cell inflammatory response via inhibition of the p38 mitogen-activated protein kinase/nuclear factor-κB pathway
- (2017) Xiaozheng Yu et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- A Randomized Dose-Escalation Study of the Safety and Anti-Inflammatory Activity of the p38 Mitogen-Activated Protein Kinase Inhibitor Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress Syndrome
- (2015) Jason D. Christie et al. CRITICAL CARE MEDICINE
- Statins May Decrease the Fatality Rate of Middle East Respiratory Syndrome Infection: FIG 1
- (2015) Shu Yuan mBio
- Safety, tolerability, pharmacokinetics and pharmacodynamics of losmapimod following a single intravenous or oral dose in healthy volunteers
- (2012) April M. Barbour et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Reactive Oxygen Species and p38 Mitogen-activated Protein Kinase Mediate Tumor Necrosis Factor α-Converting Enzyme (TACE/ADAM-17) Activation in Primary Human Monocytes
- (2011) Alasdair J. Scott et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation